Women Opting for Late Motherhood Driving Demand for Non-invasive Prenatal Testing: Transparency Market Research

ALBANY, New York, Feb. 17, 2020 /PRNewswire/ -- The global Non-Invasive Prenatal Testing Market is witnessing higher demand owing to factors such as increasing incidence of genetic abnormality in babies and increase in age of conception in women across the globe. As per Transparency Market Research, the market would chart a Compound Annual Growth Rate of 16.4% from 2019 to 2027. This growth rate will translate to higher market worth by the end of the forecast period - from USD 1.3 bn. in 2018 to USD 5.1 bn. by 2027.


"More and more women are opting for late motherhood as they focus on their jobs and want a lifestyle devoid of childbearing responsibilities in twenties and thirties - years considered crucial to progress in career. However, this increases the risk of infertility, babies contracting Down Syndrome, and preeclampsia. Thus, this becomes a major driver of growth in the NIPT market", states Transparency Market Research.

Key Findings of the Non-Invasive Prenatal Testing Market Study

    --  Trisomy test to hold a contribute massively to the growth of global
        non-invasive prenatal testing market over the assessment period; high
        prevalence of Down Syndrome to support this growth
    --  MaterniT21 to dominate growth in the market owing to strong brand
        reputation, high accuracy, and Sequenom's acquisition
    --  Growing awareness regarding need to opt for early NIPT contributing
        positively to growth of market

Explore 186 pages of top-notch research, incisive insights, and detailed country-level projections. Gain business intelligence on Non-Invasive Prenatal Testing market by Test Type: MaterniT21, Harmony, Panorama, Verifi, NIFTY, and Others; Application: Trisomy, Microdeletions Symptoms, and Others (Including Sex Chromosomes Disorders); Technology: NGS, WGS, and Others; End-user: Hospitals, Diagnostic Laboratories, and Others.

Read Detailed TOC of the Report - https://www.transparencymarketresearch.com/report-toc/374

Non-Invasive Prenatal Testing Market: Key Driving Factors

Transparency Market Research states that the global non-invasive prenatal testing market would owe its growth to a number of factors that range from increase in incidence of babies born with genetic abnormalities to changes in lifestyle that are increasing the risk factor.

    --  Some of the genetic disorders that are noting an increase in incidence
        are Turner Syndrome and Down Syndrome; high accuracy in screening test
        leading to increase in demand for NIPT
    --  As per DSE (Down Syndrome Education) International, the prevalence of
        Down Syndrome is in a range of one in 400 to one in 1500, worldwide;
        220,000 new cases of Down Syndrome are recorded annually
    --  Certain lifestyle choices, particularly dietary habits are leading to
        genetic mutation and increasing risk of certain disorders; late
        pregnancies in terms of maternal age are increasing chromosomal
        aneuploidies, leading to higher demand for NIPT

Key Impediments for Non-Invasive Prenatal Testing Market Players

Despite positive growth projected for global non-invasive prenatal testing market over the forecast period, there are restraints that are keeping the market from reaching an even higher trajectory. As per Transparency Market Research, a major restraint is resistance towards non-invasive prenatal testing from groups such as U.S. National Society of Genetic Counselors (NSGC), The American College of Obstetricians and Gynecologists (ACOG), and International Society for prenatal diagnosis. The resistance is attributable to a perception that it might lead to an increase in abortions. However, better regulations will streamline testing in the future.

Non-Invasive Prenatal Testing Market: Region-wise Analysis

    --  Countries such as Japan, the United States of America, Germany, the
        United Kingdom, France, and Italy are witnessing and increase in average
        age of mothers (first time pregnancy) owing to rising preference for
        financial stability, and higher career and educational goals over child
    --  This increases the risk of chromosomal abnormalities, leading to demand
        for non-invasive prenatal testing, particularly in the stated regions
    --  As per TMR, North America will account for major share owing to few
        other factors as well such as presence of strong players, increase in
        research and development, and an advanced healthcare industry

Analyze Non-Invasive Prenatal Testing market growth in 30+ countries including US, Canada, Germany, United Kingdom, France, Italy, Russia, Poland, Benelux, Nordic, China, Japan, India, and South Korea. Request a sample of the study.

Competition Landscape

Some of the most prominent names that operate in the global non-invasive prenatal testing market include Berry Genetics, BGI, Laboratory Corporation of America Holdings, Agilent Technologies, Inc., Illumina, Inc, F. Hoffmann-La Roche Ltd, NATERA, INC., PerkinElmer Inc., Eurofins LifeCodexx AG, and IGENOMIX among others. In an intense competitive landscape, players are directing efforts towards developing new and innovative products. Other critical strategies that help combine resources, penetrate deeper into a market, and expand business operations include alliances such as partnerships and mergers, as per Transparency Market Research. An example of product development in the recent past includes Vistara - NATERA INC.'s novel NIPT solution that is capable of screening 30 genes for abnormalities.

Purchase this Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=374&ltype=S

Transparency Market Research has segmented the Non-Invasive Prenatal Testing market based on test type, application, technology, end-user, and region.

Global Non-Invasive Prenatal Testing Market, by Test Type

    --  MaterniT21
    --  Harmony
    --  Panorama
    --  Verifi
    --  NIFTY
    --  Others

Global Non-Invasive Prenatal Testing Market, by Application

    --  Trisomy
    --  Microdeletions Symptoms
    --  Others (Including Sex Chromosomes Disorders)

Global Non-Invasive Prenatal Testing Market, by Technology

    --  NGS
    --  WGS
    --  Others

Global Non-Invasive Prenatal Testing Market, by End-user

    --  Hospitals
    --  Diagnostic Laboratories
    --  Others

Global Non-Invasive Prenatal Testing Market, by Region

    --  North America
        --  U.S.
        --  Canada
    --  Europe
        --  Germany
        --  U.K.
        --  France
        --  Spain
        --  Italy
        --  Rest of Europe
    --  Asia Pacific
        --  China
        --  Japan
        --  India
        --  Malaysia
        --  Thailand
        --  Rest of Asia Pacific
    --  Latin America
        --  Brazil
        --  Mexico
        --  Rest of Latin America
    --  Middle East & Africa
        --  South Africa
        --  GCC Countries
        --  Rest of Middle East & Africa

Explore Transparency Market Research's award-winning coverage of the global Healthcare industry:

Down Syndrome Market - Increase in research & development, introduction of novel disease therapies, rise in demand for effective therapies among patients, and increase in prevalence of the disease are projected to fuel the global Down syndrome market during the forecast period. According to the European Down syndrome Association (EDSA), Down syndrome occurs at the rate of about 1 per 1000 births.

Prenatal Testing Market - The global prenatal testing market is likely to be driven by growing number of stillbirths across the globe. Stillbirths are likely to offer sizeable growth opportunity during the period of forecast. In addition, there has been a rise in the level of awareness about prenatal testing in mostly developing countries. With better accessibility of healthcare facilities and augmented disposable income, people are choosing to know about the health of both baby and would-be mother during pregnancy.

Hepatorenal Syndrome Treatment Market - Healthcare companies are developing improved formulations of therapeutic drugs that are safe and effective for HRS patients. For instance, in May 2019, Mallinckrodt - a global specialty pharmaceutical company, announced the launch of Terlipressin - an investigational agent for the treatment of type 1 hepatorenal syndrome.

DNA and RNA Sample Preparation Market - The report finds that numerous factors are benefitting the uptake of DNA and RNA sample preparation. Those include increased allocation on medical research to find cures for various health conditions. Continued improvement in underpinning technologies is also having a positive impact on the market.

Gain access to Market Ngage, an AI-powered, real-time business intelligence that goes beyond the archaic research solutions to solve the complex strategy challenges that organizations face today. With over 15,000+ global and country-wise reports across 50,000+ application areas, Market Ngage is your tool for research on-the-go. From tracking new investment avenues to keeping a track of your competitor's moves, Market Ngage provides you with all the essential information to up your strategic game. Power your business with Market Ngage's actionable insights and remove the guesswork in making colossal decisions.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.


Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

View original content:http://www.prnewswire.com/news-releases/women-opting-for-late-motherhood-driving-demand-for-non-invasive-prenatal-testing-transparency-market-research-301005822.html

SOURCE Transparency Market Research